Crossmark

Fullerenes as photosensitizers in photodynamic therapy: pros and cons

Published Online: 2020-10-27

Published Print: 2018-11

Authors

Hamblin, Michael R.
Funding

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (R01AI050875)

National Institute of Allergy and Infectious Diseases (R21AI121700)
License Information

Text and Data Mining valid from 2018-11-01

Version of Record valid from 2018-11-01
More Information

Article History

Received: 7 May 2018

Accepted: 13 June 2018

First Online: 27 October 2020

Document is current